IP Library Granted Patent US 10,368,787
Granted Patent B2
US 10,368,787 · App. 14/711,610 · Granted Aug 6, 2019

Flowometry in optical coherence tomography for analyte level estimation

Inventors: Samuel Reichgott (Coopersburg, PA); Walter J. Shakespeare (Macungie, PA); George Kechter (Peoria, IL); Phillip William Wallace (Bernardsville, NJ); Matthew J. Schurman (Somerset, NJ)
Assignee: MASIMO CORPORATION
A61B5/14551A61B5/0066A61B5/0073A61B5/026A61B5/0261A61B5/1455A61B5/14532A61B5/14546A61B5/4875A61B5/725A61B5/7221A61B5/7278A61B2576/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,368,787
App. No.
14/711,610
Granted
Aug 6, 2019
Kind
B2
Abstract

Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.

Claims (38)

1. A method comprising:

receiving, from an optical coherence tomography apparatus, an intensity data measurement for a region of tissue;

passing the intensity data measurement through a first frequency band filter having a first bandwidth to produce a first output;

passing the intensity data measurement through a second frequency band filter having a second bandwidth that is wider than the first bandwidth to produce a second output;

determining, by a processor, an indication of fluid flow in the region of tissue by comparing the first output and the second output; and

in response to determining a positive indication of fluid flow in the region of tissue, determining, by the processor, a blood analyte measurement based on at least some of the intensity data measurement.

2. The method of claim 1 , wherein both the first bandwidth and the second bandwidth are centered at a same base frequency.

3. The method of Claim 1 , wherein the blood analyte measurement comprises a measurement of at least one of: blood glucose, blood hemoglobin, or blood oxygen.

4. The method of claim 1 , wherein determining the indication of fluid flow in the region of tissue comprises:

analyzing fringe frequency data in the first output and the second output.

5. The method of claim 4 , wherein analyzing fringe frequency data comprises:

analyzing frequency modulation in the fringe frequency data in the first output and the second output.

6. The method of claim 4 , wherein analyzing fringe frequency data comprises:

analyzing amplitude modulation in the fringe frequency data in the first output and the second output.

7. The method of claim 6 , wherein analyzing fringe frequency data further comprises:

comparing speckle intensity in the first output and the second output.

8. The method of claim 1 , wherein determining the indication of fluid flow in the region of tissue comprises:

comparing speckle intensity in the first output and the second output.

9. The method of claim 2 , wherein the intensity data measurement comprises a backscattered wide band signal.

10. A method comprising:

receiving, from an optical coherence tomography apparatus, an intensity data measurement for a region of tissue;

passing the intensity data measurement through a first filter to produce a first output;

passing the intensity data measurement through a second filter to produce a second output;

analyzing, by a processor, fringe frequency data of the first output and the second output to determine an indication of fluid flow in the region of tissue; and

in response to determining a positive indication of fluid flow in the region of tissue, analyzing, by the processor, the intensity data measurement to determine a blood analyte measurement.

11. The method of claim 10 further comprising:

analyzing a plurality of intensity data measurements for a same region of tissue to determine a blood analyte measurement.

12. The method of claim 11 , wherein the plurality of intensity data measurements are obtained at a plurality of depths in the same region of tissue.

13. The method of claim 11 , wherein the plurality of intensity data measurements are obtained at a plurality of times for the same region of tissue.

14. The method of claim 10 , wherein the blood analyte measurement comprises a measurement of at least one of: blood glucose, blood hemoglobin, or blood oxygen.

15. The method of claim 10 , wherein analyzing fringe frequency data comprises:

analyzing frequency modulation in the fringe frequency data in the first output and the second output.

16. The method of claim 10 , wherein analyzing fringe frequency data comprises:

analyzing amplitude modulation in the fringe frequency data in the first output and the second output.

17. The method of claim 16 , wherein analyzing fringe frequency data further comprises:

comparing speckle intensity in the first output and the second output.

18. The method of claim 17 , wherein determining the indication of fluid flow in the region of tissue comprises:

comparing speckle intensity in the first output and the second output.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2017
From: GLT ACQUISITION CORPORATION
To: MASIMO CORPORATION
Reel/Frame 041084/0343 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2016
From: CERCACOR LABORATORIES, INC.
To: MASIMO CORPORATION
Reel/Frame 038049/0074 →
Continuity (5)
Continuation 14063977 · Oct 25, 2013
Continuation 12397593 · Mar 4, 2009
Provisional Application 61068058 · Mar 4, 2008
Provisional Application 61033584 · Mar 4, 2008
Related Publication 20160058347A1 · Mar 3, 2016
Cited By (25)
US 1,132,251 US 12,193,813 US 12,193,849 US 12,207,419 US 12,211,617 US 12,230,396 US 12,232,905 US 12,238,489 US 12,257,022 US 12,257,183 US 12,302,426 US 12,318,175 US 12,318,229 US 12,343,108 US 12,374,843 US 12,402,843 US 12,440,171 US 12,484,844 US 12,495,968 US 12,514,503 US 12,521,039 US 12,592,009 US 12,611,117 US 12,648,718 US 12,714,369